Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™…
TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that the first patient has been treated in a U.S.…